A Critical Review of Postbiotics as Promising Novel Therapeutic Agents for Clostridial Infections.|https://dx.doi.org/10.1007/s12602-024-10406-0
Clostridioides difficile infection increases in-hospital mortality, length of stay, and hospital cost but not 30-day mortality in cirrhotic patients.|https://dx.doi.org/10.1111/jgh.16807
Antimicrobial Combinations as Novel Indicators for Clostridioides difficile infection development: Population-Based, Nested Case-Controlled Study in Japan-The Shizuoka Kokuho Database Study.|https://dx.doi.org/10.1016/j.jiac.2024.11.002
